PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Beta-glucan extracts from L. edodes significantly reduced blood parameters (RBC, HGB, HCT, and platelets) and increased lymphocyte counts in LPS-treated mice [PMID:37396940]
Daily supplementation of 30g of L. edodes in Thoroughbred racehorses resulted in higher monocyte levels at day 56 and significantly lower alkaline phosphatase levels across all sampling days [PMID:36428438]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 27566177 (2016) — Shiitake Mushroom Dermatitis: A Review. · American journal of clinical dermatology
- 2.PMID: 36012249 (2022) — Immunomodulatory Properties of Polysaccharides from Lentinula edodes. · International journal of molecular sciences
- 3.PMID: 36746560 (2023) — Proteomic characterization of Shiitake (Lentinula edodes) post-harvest fruit bodies grown on hardwood logs and isolation of an antibacterial serine protease inhibitor. · Fungal biology
- 4.PMID: 25831007 (2015) — Shiitake dermatitis. · Anais brasileiros de dermatologia
- 5.PMID: 39276893 (2024) — Molecular identification of Shiitake (Lentinula edodes), analysis and production of beta-glucan using beech wood sawdust waste.